It was used to assess the splice-altering impact of a pathogenic cryptic splice variant in the MYBPC3 intron associated with hypertrophic cardiomyopathy (ORPHA:217569) [29]. This evidence concerns the gene MYBPC3 and hypertrophic cardiomyopathy.